Stem Cell-Based Therapy and Cell-Free Therapy as an Alternative Approach for Cardiac Regeneration

Area of Science:

• Cardiovascular Medicine
• Regenerative Medicine
• Stem Cell Biology

Background:

• Cardiovascular diseases (CVDs) are a leading cause of global mortality, necessitating advanced therapeutic approaches.
• Conventional CVD treatments have limitations, driving research into novel regenerative strategies.
• Mesenchymal stem cells (MSCs) possess properties like self-renewal and immunomodulation, making them candidates for CVD therapy.

Purpose of the Study:

• To review the therapeutic potential of mesenchymal stem cells (MSCs) and their secretome for cardiovascular diseases (CVDs).
• To compare the efficacy of MSC-based therapies with their secretome-based counterparts in myocardial regeneration.
• To highlight the advantages and limitations of using MSC secretome for treating CVDs.

Main Methods:

• Review of existing literature on mesenchymal stem cells (MSCs) and their secretome in cardiovascular disease (CVD) research.
• Analysis of studies investigating the mechanisms of myocardial regeneration, focusing on paracrine factors and extracellular vesicles (EVs).
• Evaluation of clinical and preclinical data on the therapeutic effects of MSC-conditioned medium (MSC-CM).

Main Results:

• Myocardial regeneration is increasingly attributed to paracrine factors and extracellular vesicles (EVs) secreted by stem cells, rather than direct cell differentiation.
• MSC-conditioned medium (MSC-CM), or secretome, demonstrates efficacy in enhancing cardiac repair, reducing infarct size, and improving cardiac function.
• MSC-CM offers benefits comparable to MSC transplantation but avoids potential side effects associated with cell administration.

Conclusions:

• The secretome of mesenchymal stem cells (MSCs) represents a potent cell-free therapeutic strategy for cardiovascular diseases (CVDs).
• MSC-secretome therapies offer a promising, potentially safer alternative to traditional stem cell transplantation for cardiac regeneration.
• Further research into MSC secretome is warranted to optimize its application in treating cardiovascular conditions.